Drug intelligence / Profile preview

mix of 5 standardized grass pollen

Development stage
Unknown
Lead developer
Stallergenes Greer
Administration
Intradermal, Subcutaneous, Topical
01

Overview

A **standardized allergenic extract biologic** composed of five grass pollens—**agrostis gigantea pollen**, **anthoxanthum odoratum pollen**, **dactylis glomerata pollen**, **phleum pratense pollen**, and **poa pratensis pollen**—formulated as an injection solution typically standardized in **Bioequivalent Allergy Units per mL**. It has been developed by **ALK-Abello** and **Greer Laboratories** for the **diagnosis** of immediate hypersensitivity and for **allergen immunotherapy** in patients with grass-pollen allergic rhinitis or hay fever who demonstrate type I skin sensitivity to these grasses. Mechanistically, the product presents relevant grass pollen allergens to the immune system; in diagnostic use it cross-links **allergen-specific IgE** bound to mast cells to trigger immediate hypersensitivity reactions, while in repeated therapeutic administration it is intended to induce immunologic tolerance and reduce allergic symptom burden.

Other names
mix of 5 standardized grass pollenfive grass pollen extractgrass pollen allergenic extractmixed standardized grass pollen extract
02

Targets

IgE (Immunoglobulin E)

Beyond the preview

Go deeper on mix of 5 standardized grass pollen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on mix of 5 standardized grass pollen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call